ST. LOUIS CHILDREN'S HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1879-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Pain Medications in Children Undergoing Strabismus Surgery
- First Posted Date
- 2016-06-03
- Last Posted Date
- 2016-06-03
- Lead Sponsor
- St. Louis Children's Hospital
- Target Recruit Count
- 128
- Registration Number
- NCT02789969
- Locations
- 🇺🇸
St. Louis Children's Hospital, St. Louis, Missouri, United States
The Merit Study (Manual Expression pRemature InfanTs)
Not Applicable
- Conditions
- Breast Milk Expression
- First Posted Date
- 2016-05-18
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- St. Louis Children's Hospital
- Target Recruit Count
- 116
- Registration Number
- NCT02776332
- Locations
- 🇺🇸
Barnes Jewish Hospital, Saint Louis, Missouri, United States
Pharmacokinetics of Oseltamivir in Newborns and Infants
- First Posted Date
- 2011-07-06
- Last Posted Date
- 2011-07-06
- Lead Sponsor
- St. Louis Children's Hospital
- Target Recruit Count
- 19
- Registration Number
- NCT01388439
- Locations
- 🇺🇸
St. Louis Children's Hosptial, St. Louis, Missouri, United States
News
St. Louis Children's Hospital Begins Administering FDA-Approved Gene Therapy Lyfgenia for Sickle Cell Disease
St. Louis Children's Hospital is now administering Lyfgenia, an FDA-approved gene therapy developed by Bluebird Bio for treating sickle cell anemia patients.